对选择性向的结构洞察力 Candida albicans Hsp90 的选择性向
Mark E Kowalewski1, Sebastian Zagler2, Matthew R Redinbo1,2,3
1Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
Biochemistry
|May 21, 2025
概括
需要新的策略来打击耐药病原体. 研究人员确定了人类Hsp90连体结合真菌Hsp90 (CaHsp90) 的关键特征,提供了潜在的抗真菌药物标.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 药用化学 医学化学
背景情况:
- 耐药病原体的威胁日益增加,需要新的抗微生物和抗真菌策略.
- 热冲击蛋白90 (Hsp90) 是人类癌症的有效治疗标,也存在于微生物病原体中.
- 病原性真菌,如 *Candida albicans*, 拥有 Hsp90 正义体,这对它们的生存和毒性至关重要.
研究的目的:
- 研究人类Hsp90连接体对*Candida albicans*Hsp90 (CaHsp90) 的功效和选择性.
- 确定负责有效结合CaHsp90.0的关键化学特征.
- 为开发新的抗真菌剂提供对CaHsp90抑制的结构性见解.
主要方法:
- 生物化学测试以评估连接体结合亲和力和强度.
- 进行X射线晶体学以确定CaHsp90的结构,并与人类的Hsp90连接体结合.
- 基于碎片和*in silico*选,以识别和优化CaHsp90结合剂.
- 用非水解性ATP模拟物对CaHsp90进行结构分析.
主要成果:
- 几种人类的Hsp90配体表现出强烈的与CaHsp90.0结合.
- 确定了有助于有效结合CaHsp90的关键化学特征.
- 晶体结构揭示了CaHsp90核酸结合域内的各种联体的结合模式.
- 阐明了TAS116对CaHsp90的选择性抑制的结构基础.
结论:
- 人类的Hsp90配体可以适应向CaHsp90,为抗真菌药物开发提供了可行的策略.
- 结构信息为设计更强效和选择性的CaHsp90抑制剂提供了基础.
- 向CaHsp90提供了一个有希望的途径,以对抗耐药性*Candida albicans*引起的感染.
更多相关视频
12:31A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
Published on: February 28, 2015
15.1K
10:49Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
Published on: September 20, 2016
12.6K
相关概念视频
Dose-Response Relationship: Selectivity and Specificity
6.3K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.3K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
Selectins
3.2K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.2K
Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
